| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000014737 |
| Receipt No. | R000017130 |
| Official scientific title of the study | The effects of denosumab compared with oral bisphosphonates (BP) in patients with RA complicated with osteoporosis on the progression of structural damage, BMD and disease activity. |
| Date of disclosure of the study information | 2014/08/01 |
| Last modified on | 2016/08/03 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | The effects of denosumab compared with oral bisphosphonates (BP) in patients with RA complicated with osteoporosis on the progression of structural damage, BMD and disease activity. | |
| Title of the study (Brief title) | Two Birds trial | |
| Region |
|
|
| Condition | ||
| Condition | rheumatoid arthritis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to evaluate the effects of denosumab compared with BP on the progression of structural damage, BMD and disease activity in RA patients with RA |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The change in mTSS from baseline to 52 weeks |
| Key secondary outcomes | The changes from baseline to 52 weeks in DAS28,SDAI,CDAI and BMD |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Denosumab group: Denosumab 60mg is administered by subcutaneous injections every 6 months (at baseline, at 6 months and at 12 months). All patients are to take vitamin D. | |
| Interventions/Control_2 | BP group: Patients take BP continuously. All patients are to take vitamin D. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) The presence of RA, as classified according to the ACR 2010 criteria
(2) Age: from 50 years old to less than 90 years old (3) BP for more than 6 months (4) Each patients gave written informed concent. |
|||
| Key exclusion criteria | (1) Use of a biologics agent for RA within 8 weeks before trial
(2) Use of JAK inhibitor (3) Gulcocorticoid dose >10mg/day (prednisone or equivalent) (4) Patients whom the doctor judged unsuitable for participation from medical reason. |
|||
| Target sample size | 286 | |||
| Research contact person | |
| Name of lead principal investigator | Shigeru Ohno |
| Organization | Yokohama City University Medical Center |
| Division name | Center for Rheumatic diseases |
| Address | 4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan |
| TEL | 045-261-5656 |
| ohno@urahp.yokohama-cu.ac.jp | |
| Public contact | |
| Name of contact person | Akiko Suda |
| Organization | Yokohama City University Medical Center |
| Division name | Center for Rheumatic diseases |
| Address | 4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan |
| TEL | 045-261-5656 |
| Homepage URL | |
| sakiko@yokohama-cu.ac.jp | |
| Sponsor | |
| Institute | Yokohama City University Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 横浜市立大学附属市民総合医療センター(神奈川県)
横浜市立大学附属病院(神奈川県) 横浜南共済病院(神奈川県) みなと赤十字病院(神奈川県) 横浜医療センター(神奈川県) 大和市立病院(神奈川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017130 |